Vanguard Group’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
4,850,005
+11,999
| +0.2% | +$31.2K | ﹤0.01% | 2785 |
|
|
2025
Q1 | $9.19M | Buy |
4,838,006
+119,812
| +3% | +$228K | ﹤0.01% | 2893 |
|
|
2024
Q4 | $6.84M | Buy |
4,718,194
+435,008
| +10% | +$631K | ﹤0.01% | 3135 |
|
|
2024
Q3 | $7.88M | Buy |
4,283,186
+90,657
| +2% | +$167K | ﹤0.01% | 3074 |
|
|
2024
Q2 | $4.19M | Buy |
4,192,529
+40,332
| +1% | +$40.3K | ﹤0.01% | 3327 |
|
|
2024
Q1 | $8.22M | Buy |
4,152,197
+71,008
| +2% | +$141K | ﹤0.01% | 3070 |
|
|
2023
Q4 | $6.37M | Sell |
4,081,189
-26,330
| -0.6% | -$41.1K | ﹤0.01% | 3188 |
|
|
2023
Q3 | $8.09M | Buy |
4,107,519
+9,637
| +0.2% | +$19K | ﹤0.01% | 3004 |
|
|
2023
Q2 | $13M | Buy |
4,097,882
+408,556
| +11% | +$1.3M | ﹤0.01% | 2800 |
|
|
2023
Q1 | $12.1M | Buy |
3,689,326
+78,922
| +2% | +$258K | ﹤0.01% | 2838 |
|
|
2022
Q4 | $18.2M | Buy |
3,610,404
+1,229,781
| +52% | +$6.19M | ﹤0.01% | 2665 |
|
|
2022
Q3 | $5.43M | Buy |
2,380,623
+878,650
| +58% | +$2M | ﹤0.01% | 3284 |
|
|
2022
Q2 | $3.98M | Sell |
1,501,973
-70,909
| -5% | -$188K | ﹤0.01% | 3498 |
|
|
2022
Q1 | $2.16M | Hold |
1,572,882
| – | – | ﹤0.01% | 3924 |
|
|
2021
Q4 | $4.99M | Buy |
+1,572,882
| New | +$4.99M | ﹤0.01% | 3606 |
|